$ME->Wakeup('2021-02-15 00:00:00');
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The fact that another BIO company, AdVita Lifescience, who themselves are scientists were willing to sell their entire company for just shares of RLF speaks volumes IMO.
https://relieftherapeutics.com/newsblog/relief-and-advita-sign-binding-term-sheet-for-relief-to-acquire-all-shares-of-advita-to-expand-scope-of-development-of-inhaled-formulation-of-aviptadil
Best,
JB
Another down day, they need to make some moves to RESTORE DELETED investor confidence
PR's are a company's official means of communication and what should be looked at for information. Any other source is not definitive. RLF has provided plenty with significant information in each.
Best,
JB
The company has indicated in PR's that data would be released late January or early February.
PR'S ARE THE COMPANY'S OFFICIAL ANNOUNCEMENTS. Anything form any other source is thoughts, hopes or speculation and should not be relied upon as firm dates. Stick to the PR's
This means that it could happen literally any day now. Most of the investors in RLFTF have held it for a few months and remain in the green. They also have been waiting for several for months for something we now know is going to happen at any moment.
Throughout this time, we have seen a steady stream of PR's released, all of which were postive. These are exciting times indeed!
Best,
JB
Green on the Swiss exchange, everyone is holding for pending data read out. Only news has been positive, the "big one" is coming soon
Best,
JB
I do have some concerns about the Chinese government potentially taking us over. The company could become "nationalized" and a asset of the country since they seem to be very popular there. Trying to find some assurances that would not occur. Feel free to post up info regarding this
Best,
JB
I think there could be potential for some upwards movement. Still gathering DD
I have taken up a position here as a "personal pet project"
Best,
JB
The difference was Hercules Partners SA adding 30m shares
The company has said late January, early February for RCT Data... Anything else beyond that is speculation, assumption or just mere guessing. There is no cause for concern imo.
best,
JB
Many are starting to look at -- I think the information gathering has begun
Do you have a link for this? Where is this info from? Are they the same class as common shares?
Thanks for the link to the financials!
This is an interesting ticker, i am doing some research into
There is no guarantee data will be released at 1am
While I do like the recent tone, We do not know for sure if data will be released at 1am. The company has indicated late Jan or early Feb in PRs. The CMO said in a few days on linked-in but there is NOTHING saying 02/01 RCT DATA @ 1AM. What we DO know is that it is coming soon, if it does in fact come @ 1am great. If not, that's ok too. Just HOLD and have patience, there WILL be a data release at some point. It will BE AMAZING.
Managing expectations,
JB
(Proper use of CAPS for emphasis)
Oh how I pray that short report below is true.
OTC shorting is difficult to do as few brokerages will allow even (Interactive Brokers is one) and finding accurate reporting on such is even more so. I do know BIG news is coming and a short squeeze trying to get shares that informed shareholders are no releasing would only further exponentially increase share price if there are no shares for sale .
IE GME. LONG HOLD
Best,
JB
With merger completion, the rights convert to shares based on what I've read while the warrants remain. The rights should in theory be close to share price, possibly with a small premium too. These are like "stock slices" that some brokerages offer. They seem to convert upon completion.
The warrants would remain and are basically option calls with a more complicated execution mechanism. They too should be close to share price with either a small premium or perhaps a discount based on investor sentiment.
My outlook is that all of these intertwined symbols, RLFTF/ACER & NRX/BRPA(U/W/R) plays are all going to do very well. Picking which one at the right time would involve some luck, so I own them all personally. They all offer rocket ship potential.
Here's a scenario: You believe a developer is going to plan to build a office building on a certain block in NYC. There are several smaller buildings/parcels on that block currently for sale on the market. One is listed at 1.5m, one at 2.0m, and another at 2.5m. You believe they are currently undervalued already and that you will be able to get exponentially more once the mega office building plans are announced by the developer. Which one do you buy so you make money?
In this scenario, each would make you money and you would do well. Choosing which is trivial since they all would offer the same exponential gains. As for me, I would buy all of the properties...
Best,
JB
NICE TO SEE ONE OF MY FAVORITE FORUM FRIENDS ON HERE, BEEN AWHILE. THINGS ARE LOOKING GOOD HERE AND IT SEEMS LIKE THE NEAR FUTURE WILL BE EVEN BETTER. THE MYRIAD OF INTERTWINED PLAYS: RLFTF,BRPA(W/R/U),ACER ALL SHOWED GREEN WITH SOME PUSHING 50% IN A DAY. GOOD THINGS COME TO THOSE WHO WAIT.
BEST,
JB
I personally wouldn't sell my RLFTF shares solely to buy ACER shares but I see ACER as a extremely good buy though. Its more speculative and carries more risk than RLFTF but has huge potential due to its limited float. If in fact it turns out to be RLF's vehicle to get listed on NASDAQ if RLF-100 approval and ACER merger etc, It would be the only way Robinhood folks could get at it. Sure there will be RLFTF FOMO too but those smaller traders wouldn't be able to get to RLFTF due to it being an OTC in addition to the foreign transaction fees most would not want to incur. I would think a parabolic FOMO run would occur on ACER if that happens. Now that's a lot of "if's", so that would be why I would personally would not from sell RLFTF just in order to buy ACER.
Just my 2 cents though, I am into ACER with a decent amount as I averaged down to get below $4.
Best,
JB
Anyone is just guessing. How much is safe and effective treatment for a global pandemic and any other respiratory ailment worth? wThere is nothing to compare it to imo. The only thing to go on is hat the market will bear, and that remains the unknown...
Best,
JB
I am of firm belief ACER is going to be the vehicle for RLF to be listed on the NASDAQ. Due to a limited float (10m - 2m held by insiders, so 8m) it will rocket once others make this connection. It remains a bargain at the current price. RLF top line results are pending and their US partner NRX's SPAC merger with NYSE:BRPA indicated that it is in fact going through. The BRPA S4 filed yesterday included sections on ACER as well. All part of plan devised by people with many years experience in M&A's. Thinly veiled but enough to blind some, just read between the lines.
Best,
JB
There was a SEC document that said "expected" by Jan 28, there was a linked in comment that said a few days and the company said late Jan early Feb. There is no cause for concern, data readout IS coming
Best,
-JB
And it said "expected", Gilles Del Corte said in the next few days and the company has said late Jan early Feb. It could be a few days so just relax if they do in fact want to dot some i's...
Best,
JB
RLF data read out coming...
It's in there on page 173
"NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021. Additional trials are being conducted"
BRPA S-4 Filed 01/27/2021
https://sec.report/Document/0001193125-21-019278/#d56937ds4.htm
BRPAW and BRPAR will significantly move closer to BRPA now
It's in there on page 173 ...
"NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021. Additional trials are being conducted"
BRPA S-4 Filed 01/27/2021
https://sec.report/Document/0001193125-21-019278/#d56937ds4.htm
It's in there on page 173
"NeuroRx is currently conducting Phase 2b/3 clinical trials, with read out data expected by January 28, 2021. Additional trials are being conducted"
BRPA S-4 Filed 01/27/2021
https://sec.report/Document/0001193125-21-019278/#d56937ds4.htm
There is no need need for speculation, the trial results will speak for themselves. It looks to me to be a comprehensive analysis for large investors to use. It contains a significant amount of factual positive information but it also indicates the shares are undervalued currently.
Think about the actions undertaken recently, they seem to align perfectly with a company that is about to announce their successful trial results. They have seen the unblinded data and know the "rough" results. A great deal of double checking and validation will be put into each metric before the results are publicly released. I am just holding tight for those results, they are all that matter.
Notice all the "sky is falling" RLFTF noise, it is not there to save you. Ask yourself what would be the motivation then... Results are coming, everyone knows that. Recent company activity even points to those results being quite good. Have patience and ignore the noise.
Best,
JB
We all know RLFTF news is coming soon. The RLFTF FUD noise machines are in full swing!
RLF put on their site a 62 page "Analyst Coverage" link @ https://www.relieftherapeutics.com/investor-relations
RLF is getting ready for something... it surely is not to announce a disappointment. The RLFTF FUD noise machines know this too.
Patience,
JB
Waiting on RLF-100 trial data to be released. The company has indicated late January early February for this to occur. The RLFTF FUD noise machines seem to be cranking up about the stock -- Just have patience.
Best,
JB
Video and link has been listed in the intro to this board for months
When something has value, it is often counterfeited. Imitation is the greatest form of flattery. The article itself is questionable but part of me wants it to be true so a ohase 3 trial is conducted in India at Dr Reddys expense and to seek damages for patent infringement. Bottom line is that news is going to drop and they know it. Do your DD, ignore the noise and be patient.
Best,
JB
Sit back for a moment and try "thinking"...
If a company who just unblinded their data from a randomized controlled trial and had any concerns about those same trial results, they would NOT announce a collaboration with some obscure NASDAQ listed company who makes a drug for some obscure ailment. They would not "give" $1m away to do so, they would not "loan" $4m to be secured by a "lien on all of Acer's assets" either.
Now, if that same company wanted a fast track approach to be listed on the NASDAQ for "some reason", oh say that they just unblinded their data and it looks great, they would definitely do this. To me it seems quite clear what is about the occur but thinly veiled enough to blind some apparently.
Best,
JB
Maybe people know it exists but "someone" scares them away when they look into it?... ¯\_(?)_/¯
When the trial data comes out, all will benefit.
I do not believe RLF's interest is in ACERs drug for the maple syrup urine condition, there is an underlying motive imo.
I do know shares of ACER are limited, many dropped BRPA to move to ACER and more will follow soon.
Regardless, we must wait patiently and find out. Just holding
Best,
JB
Profit taking to get into the new shiny ticker. Not everyone has dry powder
Welcome aboard TB, this will rally like the others. Upon RCT data, they all will hit. This is THE "vehicle" IMO, ducks in a row & stars aligning.
Best,
JB
The stars are aligning....
Without a merger it can be difficult. There are 4 paths:
https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/
So 12 months with Standard #3 but possibly standard #4 which is the toughest based on assets. NASDAQ is an exclusive club....
RLF's interest in ACER is clear to me
Best,
JB